The Effects of Corneal Collagen Cross-linking

Last updated: October 24, 2022
Sponsor: Rush Eye Associates
Overall Status: Active - Recruiting

Phase

3

Condition

Vision Loss

Eye Disease

Treatment

N/A

Clinical Study ID

NCT01708538
Rush CXL
  • Ages 10-70
  • All Genders

Study Summary

The corneal collagen cross-linking treatment has been used with increasing success to treat corneal dystrophies such as "keratoconus." Recent advances have allowed different techniques for performing this cross-linking treatment. This study investigates the effects of corneal cross-linking using different surgical techniques.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 10-70, willing to participate, diagnosis of corneal ectasia disorder

Exclusion

Exclusion Criteria:

  • Unwilling or unable to participate in trial

Study Design

Total Participants: 30
Study Start date:
October 01, 2012
Estimated Completion Date:
October 31, 2024

Connect with a study center

  • Rush Eye Associates

    Amarillo, Texas 79106
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.